✦ LIBER ✦

The Existential Question in Palliative Sedation: Reply to Putman et al.

✍ Scribed by Dirksen, Kevin M.; Hynds, James A.; Bhavsar, Ayesha R.; Brown-Saltzman, Katherine

Book ID: 125422132
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 40 KB
Volume: 45
Category: Article
ISSN: 0885-3924
DOI: 10.1016/j.jpainsymman.2012.12.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What’s in a Name? Palliative Sedation in

What’s in a Name? Palliative Sedation in Belgium. Reply to Chambaere et al.

✍ Bert Broeckaert; Patricia Claessens; Paul Schotsmans; Johan Menten 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Deep sedation compared with moderate sed

Deep sedation compared with moderate sedation in polyp detection during colonoscopy: a randomized controlled trial : Reply to Paspatis et al.

✍ A. K. Banerjee; A. Oshowo; H. Mukhtar; D. Suri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

Understanding the Impact of Withdrawing

Understanding the Impact of Withdrawing From Phase III Studies in Palliative Care: Reply to Johnson et al.

✍ David C. Currow; Gregory P. Samsa; Amy P. Abernethy 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 46 KB

In response to the reply by Roach et al.

✍ Howard M. Sandler; Ronald W. McCallum 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 332 KB

In reply to the letter by Gevaert et al.

✍ Jozien Helleman; Maurice P.H.M. Jansen; Maria E.L. van der Burg; Els M.J.J. Bern 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 40 KB

raised an important issue about the implementation in clinical practice of the 9-gene set for platinum resistance of ovarian cancer patients. They also stated that nonplatinum containing regimens are suboptimal in the treatment of ovarian cancer. In our study 1 we have included specimens of 96 prim

Let the right one in: reply to Hulme et

Let the right one in: reply to Hulme et al. and van Kleunen et al.

✍ Ken Thompson; Mark A. Davis 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 64 KB